What it takes for new medicines to access the market

Before a new medical product can be sold in Switzerland, it requires an establishment licence granted by Swissmedic, the Swiss Agency for Therapeutic Products. The authorization procedure is complex, involving a lot of tests and paper work. (swissinfo, Michele Andina)

This content was published on May 11, 2009

Contributions under this article have been turned off. You can find an overview of ongoing debates with our journalists here. Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at

Sort by

Change your password

Do you really want to delete your profile?

Your subscription could not be saved. Please try again.
Almost finished... We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.

Weekly top stories

Keep up to date with the best stories from SWI on a range of topics, straight into your mailbox.


The SBC Privacy Policy provides additional information on how your data is processed.